| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Sirish Kumar Ravula
Appointed as Director since October 2022 |
Director | 01-Oct-2022 | Current |
|
Premium access
Complete director detailsUnlock the complete director and KMP records available for Devi Pharmatech Private Limited.
Verified entity values are shown only after access is granted. |
|||
|
Ravi Kumar Yerra
Appointed as Director since October 2022 |
Director | 01-Oct-2022 | Current |
|
Veerendra Yarlagadda
Appointed as Director since March 2021 |
Director | 13-Mar-2021 | Current |
|
Samarendra Yarlagadda
Appointed as Director since October 2020 |
Director | 13-Oct-2020 | Current |
|
Mahendra Yarlagadda
Appointed as Director since October 2020 |
Director | 13-Oct-2020 | Current |
|
Sri Darma Sasta Surendra Yarlagadda
Appointed as Director since October 2021 |
Director | 20-Oct-2021 | Current |
|
Indraneel Chitturi
Appointed as Director since October 2021 |
Director | 20-Oct-2021 | Current |
People Timeline
Explore the timeline of key personnel in Devi Pharmatech Private Limited's leadership journey.
Loading...
Contact Details
- Address D.No. 6-21-7, East Point Colony,, Visakhapatnam Andhra Pradesh, 530017, India
- Telephone Upgrade
- Email Upgrade
- Pin Code 530017
- Country India
- Website devipharmatech.com
Frequently Asked Questions
You can contact Devi Pharmatech Private Limited through their registered address at D.No. 6-21-7, East Point Colony,, Visakhapatnam Andhra Pradesh, 530017, India, or via their website at devipharmatech.com. Social media links are also provided where applicable.
The current directors of Devi Pharmatech Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
- SIRISH KUMAR RAVULA
- SAMARENDRA YARLAGADDA
- MAHENDRA YARLAGADDA
- VEERENDRA YARLAGADDA
- SRI DARMA SASTA SURENDRA YARLAGADDA
- INDRANEEL CHITTURI
- RAVI KUMAR YERRA
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.